- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $619.16M |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $282.29M |
| Short Term Investments | Q3 2025 · Mar 31, 2025 | $10M |
| Short Term Investments | Q3 2025 · Jun 30, 2024 | $44M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $60.35M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $70.61M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $265.99M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $256.64M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $266.48M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $204.15M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $1.05B |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $725.54M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $776.02M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $601M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $1.32B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $982.18M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 40.52M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 40.51M sh |
| Dividends Paid | Q3 2025 · Mar 31, 2024 | $14.58M |
| Capex | Q3 2025 · Mar 31, 2024 | $28.17M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $59.17M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.21 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.04 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.21 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.04 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $59.68M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $191.04M |
| Net Income | Q3 2025 · Mar 31, 2024 | $8.41M |
| Net Income | Q3 2025 · Mar 31, 2024 | $1.66M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $19.92M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $34.9M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $79.6M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $225.94M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $183.62M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $518.57M |
| Revenue | Q3 2025 · Mar 31, 2024 | $263.22M |
| Revenue | Q3 2025 · Mar 31, 2024 | $744.52M |